Home / Products & pipeline

Products & pipeline

IVS-5001 – the Anti-ILT4 Nanobody

Novel molecules to generate ICP inhibitors VHH molecules are derived from immunoglobulins expressed by certain species of camelids (notably Alpacas). These are shorter,…

Read more

IVS-4001 – anti-HLA-G Monoclonal Antibodies

Blocking immunosuppressive pathways a) Monoclonal antibodies and cancer In order to maintain homeostasis, the immune system response is balanced by stimulating and…

Read more

IVS-3001 : anti-HLA-G CAR T cells

Modified autologous CAR T cells to eliminate HLA-G-bearing cancer cells a) What are CAR-T cells? Chimeric Antigen Receptors (CARs) are artificial receptors, derived…

Read more

Invectys’ pipeline

Pipeline Depth Underpinned by Multiple Indications and Platforms Invectys Inc. develops a full range of innovative and very promising immunotherapeutic oncology…

Read more

HLA-G platform

HLA-G: from pregnancy to tumors Invectys Inc. targets a powerful immune checkpoint named HLA-G. HLA-G is a non-classical MHC class I molecule normally only expressed…

Read more

IVS-2001 : A DNA vaccine targeting cancer

A DNA vaccine targeting a specific cancer marker Cancer cells produce an enzyme which is key to their unlimited proliferation, but is nearly never expressed in normal…

Read more

IVS-1001 : a UCP Vaccine enhancing CD4+ response

Using specific cancer markers to turn “cold” tumors “hot” Cells will express on their surface short protein fragments – peptides – corresponding to proteins…

Read more